Publication year: 2011
Source: Current Opinion in Cell Biology, Available online 16 September 2011
Koichi Araki, Ali H Ellebedy, Rafi Ahmed
The target of rapamycin (TOR) is a crucial intracellular regulator of the immune system. Recent studies have suggested that immunosuppression by TOR inhibition may be mediated by modulating differentiation of both effector and regulatory CD4 T cell subsets. However, it was paradoxically shown that inhibiting TOR signaling has immunostimulatory effects on the generation of long-lived memory CD8 T cells. Beneficial effects of TOR inhibition have also been observed with dendritic cells and hematopoietic stem cells. This immune modulation may contribute to lifespan extension seen in mice with mTOR inhibition. Here, we review recent findings on TOR modulation of innate and adaptive immune responses, and discuss potential applications of regulating TOR to provide longer and healthier immunity.
Highlights
► mTOR regulates memory CD8 T cell differentiation. ► Differentiation into both effector and regulatory CD4 T cells is modulated by mTOR. ► mTOR has both stimulatory and inhibitory effects on DCs. ► Inhibiting mTOR has anti-aging effects and extends life span. ► Rapamycin rejuvenates functional ability of HSCs from aged mice.